Duration of antimicrobial therapy for nosocomial pneumonia: possible strategies for minimizing antimicrobial use in intensive care units

被引:8
|
作者
Dugan, HA [1 ]
MacLaren, R [1 ]
Jung, R [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Denver, CO 80262 USA
关键词
duration of antibiotic therapy; nosocomial pneumonia; shorter course;
D O I
10.1046/j.1365-2710.2003.00471.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To review published data evaluating shorter courses of antibiotic therapy for nosocomial pneumonia and provide recommendations for minimizing antimicrobial use in intensive care units. Data source: Literature was identified through MEDLINE (1966 through 6/2002) and a manual search of critical care, infectious disease, and pharmacy journals was conducted to identify relevant abstracts. Data synthesis: Antibiotic use may be decreased by discontinuing therapy after 3 days in patients with low likelihood of nosocomial pneumonia. In addition, clinical guidelines or invasive diagnostic procedures may be effectively instituted to reduce duration of antibiotic therapy. Conclusion: Shorter-course antibiotic therapy may be beneficial in decreasing lengths of hospital and intensive care units stays, antimicrobial resistance, and total hospital costs. Further research is needed to determine the optimal duration of therapy in patients with nosocomial pneumonia.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [1] Use of Procalcitonin to Guide Duration of Antimicrobial Therapy in Intensive Care Units: Proceed With Caution
    Manian, Farrin A.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (04)
  • [2] Nosocomial bacteraemia & antimicrobial resistance in intensive care units
    Mathai, E
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 122 (04) : 285 - 287
  • [3] Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units
    Elisabeth Meyer
    Frank Schwab
    Daniel Jonas
    Henning Rueden
    Petra Gastmeier
    Franz D. Daschner
    Intensive Care Medicine, 2004, 30 : 1089 - 1096
  • [4] Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units
    Meyer, E
    Schwab, F
    Jonas, D
    Rueden, H
    Gastmeier, P
    Daschner, FD
    INTENSIVE CARE MEDICINE, 2004, 30 (06) : 1089 - 1096
  • [5] Economic impact of new forms of antimicrobial treatment for nosocomial pneumonia in cardiovascular intensive care units
    Rodriguez Acosta, Andres M.
    Cuellar Perez, Juan C.
    Abilio Luciano, Candido S.
    CORSALUD, 2015, 7 (02): : 151 - 153
  • [6] Procalcitonin to Guide Duration of Antimicrobial Therapy in Intensive Care Units: A Systematic Review
    Agarwal, Rajender
    Schwartz, David N.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (04) : 379 - 387
  • [7] Overview of antimicrobial therapy in intensive care units
    Textoris, Julien
    Wiramus, Sandrine
    Martin, Claude
    Leone, Marc
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (01) : 97 - 109
  • [8] Antimicrobial use and antimicrobial resistance in Intensive Care Units; 2001-2008
    Meyer, E.
    Schwab, F.
    Schroeren-Boersch, B.
    Gastmeier, P.
    INFECTION, 2009, 37 : 48 - 48
  • [9] Introduction: Nosocomial Pneumonia in Intensive Care Units
    Williams, J. D.
    JOURNAL OF CHEMOTHERAPY, 2001, 13 : 202 - 204
  • [10] Antimicrobial use and the influence of inadequate empiric antimicrobial therapy on the outcomes of nosocomial bloodstream infections in a neonatal intensive care unit
    Apisarnthanarak, A
    Holzmann-Pazgal, G
    Hamvas, A
    Olsen, MA
    Fraser, VJ
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (09): : 735 - 741